Kadmon Holdings Inc Asset Turnover Ratio (KDMN), as of third quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kadmon holdings inc   (NASDAQ: KDMN)
 

Kadmon Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kadmon Holdings Inc asset turnover ratio, the ability of Kadmon Holdings Inc 's assets to generate revenue in the third quarter 2021, increased sequentially to 0.05 in the third quarter (Sep 30 2021), yet the ratio remained below the average, as KDMN's position remain challenging.

Within sector 194 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2021 compared to the preceding quarter from 3266 to 3350.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KDMN Asset Turnover Ratio (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Asset Change 62.98 % 47.09 % 86.71 % 33.41 % 21.56 %
Y / Y Revenue Change 2901.22 % -56.03 % -91.64 % -86.03 % 116.81 %
Asset Turnover Ratio (TTM) 0.05 0.01 0.01 0.04 0.06
KDMN's Total Ranking # 3350 # 3266 # 3370 # 3266 # 3266
Seq. Asset Change -1.94 % -7.41 % 16.94 % 53.5 % -11.5 %
Seq. Revenue Change 7364.97 % -65.01 % -8.46 % 25.51 % 9.37 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 195
Healthcare Sector # 539
Overall Market # 3350

Asset Turnover Ratio Statistics
High Average Low
23.74 9.42 0.81
(Mar 31 2017)   (Sep 30 2019)




KDMN Company Profile • Back to KDMN Efficiency Comparisons • Compare KDMN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2021 Assets at quarter ending Sep 30 2021
Guardion Health Sciences Inc   0.14 $ 4.806  Millions$ 33.615  Millions
Organigram Global Inc   0.14 $ 62.459  Millions$ 438.686  Millions
Therapeutic Solutions International Inc   0.14 $ 0.120  Millions$ 0.848  Millions
Theravance Biopharma inc   0.14 $ 59.095  Millions$ 419.131  Millions
Adaptive Biotechnologies Corporation  0.14 $ 146.599  Millions$ 1,053.622  Millions
Kymera Therapeutics Inc   0.14 $ 70.342  Millions$ 507.142  Millions
Q32 Bio Inc   0.14 $ 34.149  Millions$ 247.042  Millions
Royalty Pharma Plc  0.14 $ 2,285.906  Millions$ 16,545.411  Millions
Aspira Women s Health inc   0.14 $ 6.407  Millions$ 46.445  Millions
Electrocore Inc   0.14 $ 4.889  Millions$ 36.034  Millions
Harpoon Therapeutics Inc   0.13 $ 26.821  Millions$ 200.939  Millions
Invo Fertility Inc   0.13 $ 1.308  Millions$ 9.804  Millions
Nutriband Inc   0.13 $ 1.278  Millions$ 9.587  Millions
Chemocentryx Inc.  0.13 $ 64.176  Millions$ 485.132  Millions
Acceleron Pharma inc  0.13 $ 112.763  Millions$ 858.008  Millions
Dariohealth Corp   0.13 $ 13.241  Millions$ 101.941  Millions
Dmk Pharmaceuticals Corporation  0.13 $ 7.066  Millions$ 55.077  Millions
Accelerate Diagnostics Inc   0.13 $ 11.548  Millions$ 90.311  Millions
Merus N v   0.13 $ 43.414  Millions$ 341.169  Millions
Sangamo Therapeutics Inc   0.13 $ 108.515  Millions$ 855.852  Millions
Spero Therapeutics Inc   0.12 $ 17.419  Millions$ 140.294  Millions
Kineta Inc   0.12 $ 10.869  Millions$ 89.549  Millions
Hookipa Pharma inc   0.12 $ 19.716  Millions$ 166.522  Millions
Intelgenx Technologies Corp   0.12 $ 1.831  Millions$ 15.605  Millions
Pulmatrix Inc   0.12 $ 6.713  Millions$ 57.300  Millions
Histogen Inc   0.12 $ 2.986  Millions$ 25.546  Millions
Catheter Precision Inc   0.12 $ 3.345  Millions$ 28.735  Millions
Bespoke Extracts Inc  0.12 $ 0.036  Millions$ 0.308  Millions
Regenxbio Inc   0.12 $ 93.137  Millions$ 806.101  Millions
Molecular Templates Inc   0.11 $ 24.230  Millions$ 213.585  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.